B*CURED’s primary goal is to fund innovative brain cancer research to end brain cancer. We invite clinical doctors and research scientists whose primary focus is brain cancer to apply for our grants.

Apply for a 2019 Research Grant

The 2019 grant program is now open. Please click on the following for access to the 2019 Grant Application and Frequently Asked Questions FAQs.

Clinical and translational projects with significant clinical promise will be considered. Both adult and pediatric brain cancer projects will be considered.

Submit your application via email at or mail it to
B*CURED | ATTN: Research | PO Box 1071 | Greenwich, CT 06836
For further information or questions, please contact us at
  • Bryan Choi, 2018 NREF - B*CURED Grant Recipient
    Massachusetts General Hospital
    Study a chimeric antigen receptor T cell targeting the tumor-specific mutation of epidermal growth factor receptor (CART-EGFRvIII) in therapy for GBM.
  • Baoli Hu
    University of Pittsburgh, Children's Hospital
    Delineating WNT5A Signaling in Anti-VEGF Therapy-induced Glioblastoma Invasiveness
  • David Reardon, 2018 David A. Koch Memorial Grant Recipient
    Massachusetts General Hospital
    Preclinical Efficacy and Scheduling of Personalized Neoantigen Vaccine and PD-1 Blockade Combination Therapy for Glioblastoma
  • Atsuo Sasaki
    University of Cincinnati
    Synthetic lethal Induction of Methuosis—non-apoptotic death—in PTEN-deficient Glioblastoma
  • Roel Verhaak
    Jackson Lab for Genomic Research
    Targeting ribonucleotide reductase for the treatment of glioblastoma
  • Yi Fan
    University of Pennsylvania
    Development of Microphage-Directed Immunotherapy for Glioblastoma